SEARCH

SEARCH BY CITATION

References

  • 1
    Weis M, Von Scheidt W. Coronary artery disease in the transplanted heart. Annu Rev Med 2000; 51: 81100.
  • 2
    Hutchinson IV. Cardiac allograft vasculopathy–the cellular attack. Z Kardiol 2000; 89(Suppl 9): 1620.
  • 3
    Russell ME, Wallace AF, Hancock WW et al. Upregulation of cytokines associated with macrophage activation in the Lewis-to-F344 rat transplantation model of chronic cardiac rejection. Transplantation 1995; 59: 572578.
  • 4
    Libby P, Pober JS. Chronic rejection. Immunity 2001; 14: 387397.
  • 5
    Alpers CE, Davis CL, Barr D, Marsh CL, Hudkins KL. Identification of platelet-derived growth factor A and B chains in human renal vascular rejection. Am J Pathol 1996; 148: 439451.
  • 6
    Hayry P, Myllarniemi M, Aavik E et al. Stabile D-peptide analog of insulin-like growth factor-1 inhibits smooth muscle cell proliferation after carotid ballooning injury in the rat. FASEB J 1995; 9: 13361344.
  • 7
    Sihvola R, Koskinen P, Myllarniemi M et al. Prevention of cardiac allograft arteriosclerosis by protein tyrosine kinase inhibitor selective for platelet-derived growth factor receptor. Circulation 1999; 99: 22952301.
  • 8
    Yun JJ, Fischbein MP, Whiting D et al. The role of MIG/CXCL9 in cardiac allograft vasculopathy. Am J Pathol 2002; 161: 13071313.
  • 9
    Yun JJ, Fischbein MP, Laks H et al. Rantes production during development of cardiac allograft vasculopathy. Transplantation 2001; 71: 16491656.
  • 10
    Uehara S, Chase CM, Kitchens WH et al. NK cells can trigger allograft vasculopathy: The role of hybrid resistance in solid organ allografts. J Immunol 2005; 175: 34243430.
  • 11
    Corry RJ, Winn HJ, Russell PS. Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K and non-H-2 antigen in rejections. Transplantation 1973; 16: 343350.
  • 12
    Goldmann O, Rohde M, Chhatwal GS, Medina E. Role of macrophages in host resistance to group A streptococci. Infect Immun 2004; 72: 29562963.
  • 13
    Debrick JE, Campbell PA, Staerz UD. Macrophages as accessory cells for class I MHC-restricted immune responses. J Immunol 1991; 147: 28462851.
  • 14
    Allison AC, Harington JS, Birbeck M. An examination of the cytotoxic effects of silica on macrophages. J Exp Med 1966; 124: 141154.
  • 15
    Adding LC, Bannenberg GL, Gustafsson LE. Basic experimental studies and clinical aspects of gadolinium salts and chelates. Cardiovasc Drug Rev 2001; 19: 4156.
  • 16
    Russell PS, Chase CM, Winn HJ, Colvin RB. Coronary atherosclerosis in transplanted mouse hearts. I. Time course, immunogenetic and immunopathological considerations. Am J Path 1994; 144: 260274.
  • 17
    Russell PS, Chase CM, Winn HJ, Colvin RB. Coronary atherosclerosis in transplanted mouse hearts. III. Effects of recipient treatment with a monoclonal antibody to interferon-g. Transplantation 1994; 57: 13671371.
  • 18
    Armstrong AT, Strauch AR, Starling RC, Sedmak DD, Orosz CG. Morphometric analysis of neointimal formation in murine cardiac allografts. Transplantation 1997; 63: 941947.
  • 19
    Piriou L, Chilmonczyk S, Genetet N, Albina E. Design of a flow cytometric assay for the determination of natural killer and cytotoxic T-lymphocyte activity in human and in different animal species. Cytometry 2000; 41: 289297.
  • 20
    Van Rooijen N, Sanders A. Liposome mediated depletion of macrophages: Mechanism of action, preparation of liposomes and applications. J Immunol Methods 1994; 174: 8393.
  • 21
    Takayama J, Koyamada N, Abe T et al. Macrophage depletion prevents accelerated rejection and results in long-term survival in hamster to rat cardiac xenotransplantation. Transplant Proc 2000; 32: 1016.
  • 22
    Oliani SM, Paul-Clark MJ, Christian HC, Flower RJ, Perretti M. Neutrophil interaction with inflamed postcapillary venule endothelium alters annexin I expression. Am J Pathol 2001; 158: 603615.
  • 23
    DeSimone JM, Meguid MM, Kurzer M, Westervelt J. Indomethacin decreases carrageenan-induced peritoneal adhesions. Surgery 1998; 104: 788795.
  • 24
    Azuma H, Nadeau KC, Ishibashi M, Tilney NL. Prevention of functional, structural, and molecular changes of chronic rejection of rat renal allografts by a specific macrophage inhibitor. Transplantation 1995; 60: 15771582.
  • 25
    Raisanen-Sokolowski A, Yilmaz S, Tufveson G, Hayry P. Partial inhibition of allograft arteriosclerosis (chronic rejection) by 15-deoxyspergualin. Transplantation 1994; 57: 17721777.
  • 26
    Shi C, Lee WS, He Q et al. Immunologic basis of transplant-associated arteriosclerosis. Proc Natl Acad Sci U S A 1996; 93: 40514056.
  • 27
    Guleria I, Pollard JW. Aberrant macrophage and neutrophil population dynamics and impaired Th1 response to listeria monocytogenes in colony-stimulating-factor-1-deficient mice. Infect Immunol 2001; 69: 1951807.
  • 28
    Lu L, Osmond DG. Regulation of cell survival during B lymphopoiesis in mouse bone marrow: Enhanced pre-B-cell apoptosis in CSF-1-deficient op/op mutant mice. Exp Hematol 2001; 29: 596601.
  • 29
    Wiktor-Jedrzejczak W. In vivo role of macrophage growth factors as delineated using CSF-1 deficient op/op mouse. Leukemia 1993; 7(Suppl 2):S117S121.
  • 30
    Mackaness GB. The Immunological Basis of Acquired Cellular Resistance. J Exp Med 1964; 120: 105120.
  • 31
    Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003; 3: 2335.
  • 32
    Wyburn KR, Jose MD, Wu H, Atkins RC, Chadban SJ. The role of macrophages in allograft rejection. Transplantation 2005; 80: 16411647.
  • 33
    Vabulas RM, Ahmad-Nejad P, Ghose S, Kirschning CJ, Issels RD, Wagner H. HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway. J Biol Chem 2002; 277: 1510715112.
  • 34
    Zhai Y, Shen XD, O'Connell R et al. Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway. J Immunol 2004; 173: 71157119.
  • 35
    Kodelja V, Muller C, Tenorio S, Schebesch C, Orfanos CE, Goerdt S. Differences in angiogenic potential of classically vs alternatively activated macrophages. Immunobiology 1997; 197: 478493.
  • 36
    Hornick PI, Mason PD, Baker RJ et al. Significant frequencies of T cells with indirect anti-donor specificity in heart graft recipients with chronic rejection. Circulation 2000; 101: 24052410.
  • 37
    Weis M, Cooke JP. Cardiac allograft vasculopathy and dysregulation of the NO synthase pathway. Arterioscler Thromb Vasc Biol 2003; 23: 567575.
  • 38
    Hurtrel B, Lagrange PH. Comparative effects of carrageenan on systemic candidiasis and listeriosis in mice. Clin Exp Immunol 1981; 44: 355358.
  • 39
    Tellides G, Tereb DA, Kirkiles-Smith NC et al. Interferon-gamma elicits arteriosclerosis in the absence of leukocytes. Nature 2000; 403: 207211.
  • 40
    Pilmore HL, Painter DM, Bishop GA, McCaughan GW, Eris JM. Early up-regulation of macrophages and myofibroblasts: A new marker for development of chronic renal allograft rejection. Transplantation 2000; 69: 26582662.
  • 41
    Shimizu A, Yamada K, Sachs DH, Colvin RB. Mechanisms of chronic renal allograft rejection. II. Progressive allograft glomerulopathy in miniature swine. Lab Invest 2002; 82: 673686.
  • 42
    Oyaizu T, Okada Y, Shoji W et al. Reduction of recipient macrophages by gadolinium chloride prevents development of obliterative airway disease in a rat model of heterotopic tracheal transplantation. Transplantation 2003; 76: 12141220.
  • 43
    Hoch JR, Stark VK, Van Rooijen N, Kim JL, Nutt MP, Warner TF. Macrophage depletion alters vein graft intimal hyperplasia. Surgery 1999; 126: 428437.
  • 44
    Danenberg HD, Fishbein I, Gao J et al. Macrophage depletion by clodronate-containing liposomes reduces neointimal formation after balloon injury in rats and rabbits. Circulation 2002; 106: 599605.
  • 45
    Danenberg HD, Golomb G, Groothuis A et al. Liposomal alendronate inhibits systemic innate immunity and reduces in-stent neointimal hyperplasia in rabbits. Circulation 2003; 108: 27982804.
  • 46
    Drath DB, Kahan BD. Phagocytic cell function in response to immunosuppressive therapy. Arch Surg 1984; 119: 156160.
  • 47
    Comalada M, Valledor AF, Sanchez-Tillo E, Umbert I, Xaus J, Celada A. Macrophage colony-stimulating factor-dependent macrophage proliferation is mediated through a calcineurin-independent but immunophilin-dependent mechanism that mediates the activation of external regulated kinases. Eur J Immunol 2003; 33: 30913100.
  • 48
    Pakala R, Stabile E, Jang GJ, Clavijo L, Waksman R. Rapamycin attenuates atherosclerotic plaque progression in apolipoprotein E knockout mice: Inhibitory effect on monocyte chemotaxis. J Cardiovasc Pharmacol 2005; 46: 481486.
  • 49
    Eisen HJ, Tuzcu EM, Dorent R et al. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. N Engl J Med 2003; 349: 847858.